Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Nothing to See Here, No Huge Sales Yet
Motley Fool
Friday, August 2, 2013 - 1:00pm
tags:
Arena Pharmaceutical, Belviq, Eisai, obesity
Progress In Asthma Drug Therapy From A Patient's View
Forbes
Friday, August 2, 2013 - 12:09pm
tags:
asthma, patients, Advair
Immunogen Earnings: Here’s Why Shares are Up Now
Wall St. Cheat Sheet
Friday, August 2, 2013 - 11:58am
tags:
Immunogen, earnings
Innovative KaloBios Pharmacuticals Could Be A Lucrative Buy
Seeking Alpha
Friday, August 2, 2013 - 11:50am
tags:
KaloBios
India revokes GSK cancer drug patent in latest Big Pharma blow
Reuters
Friday, August 2, 2013 - 11:03am
tags:
GSK, India, patents, Tykerb
Actelion buys U.S.-based specialty drugmaker Ceptaris
Reuters
Friday, August 2, 2013 - 11:02am
tags:
Actelion, M&A, Ceptaris
Valeant CEO Blasted By NY Pols For Moving Bausch + Lomb HQ
Pharmalot
Friday, August 2, 2013 - 11:00am
tags:
Valeant Pharmaceuticals, Bausch & Lomb
StemCells presents two-year PMD data
Yahoo/Fly on the Wall
Friday, August 2, 2013 - 10:59am
tags:
StemCells, Pelizaeus-Merzbacher disease, HuCNS-SC cells
Arena And Vivus - Why Insurance Is So Important
Seeking Alpha
Friday, August 2, 2013 - 10:58am
tags:
Arena Pharmaceuticals, Vivus, Belviq, insurance, obesity, Qsymia
Theravance announces FDA Advisory Committee to review Anoro Ellipta
Yahoo/Fly on the Wall
Friday, August 2, 2013 - 10:56am
tags:
FDA, advisory panels, Anoro Ellipta, Theravance, COPD
How China's Probe of GlaxoSmithKline Could Play Out
TheStreet.com
Friday, August 2, 2013 - 10:55am
tags:
China, GSK
GlaxoSmithKline diabetes drug faces U.S. approval delay
Reuters
Friday, August 2, 2013 - 10:54am
tags:
GSK, diabetes, albiglutide, FDA
Bayer Lung Drug Should Be Approved at Low Dose, FDA Says
Bloomberg
Friday, August 2, 2013 - 10:53am
tags:
Bayer, FDA, drug approvals, pulmonary hypertension, Riociguat
Endo Health Solutions Earnings Are on Deck
Motley Fool
Friday, August 2, 2013 - 10:52am
tags:
Endo Health Solutions, earnings
Earnings Beat at Mylan
Yahoo/Zacks
Friday, August 2, 2013 - 10:51am
tags:
Mylan, earnings
FDA warns of serious skin rash with acetaminophen pain pills
Reuters
Friday, August 2, 2013 - 10:49am
tags:
FDA, warnings, acetaminophen
Pacira Pharma surgical pain drug Exparel fails in new clinical trial; still plans new filings
Yahoo/AP
Friday, August 2, 2013 - 10:48am
tags:
Pacira, clinical trials, EXPAREL
Teva Pharmaceutical Industries a Top Ranked SAFE Dividend Stock With 3.2% Yield
Forbes
Thursday, August 1, 2013 - 9:49am
tags:
Teva Pharmaceuticals
Ligand Reports Second Quarter Financial Results
Enhanced Online News
Thursday, August 1, 2013 - 9:48am
tags:
Ligand, earnings
Quintiles' $944M in 2Q revenue beats analyst estimates
WRAL TechWire
Thursday, August 1, 2013 - 9:46am
tags:
Quintiles, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.